These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 22609107

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
    Koul A, Willén R, Bendahl PO, Nilbert M, Borg A.
    Cancer; 2002 May 01; 94(9):2369-79. PubMed ID: 12015762
    [Abstract] [Full Text] [Related]

  • 9. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
    Kim JH, Rhee YY, Kim KJ, Cho NY, Lee HS, Kang GH.
    APMIS; 2014 Dec 01; 122(12):1187-95. PubMed ID: 24909058
    [Abstract] [Full Text] [Related]

  • 10. Defective mismatch repair and the development of recurrent endometrial carcinoma.
    Pijnenborg JM, Dam-de Veen GC, de Haan J, van Engeland M, Groothuis PG.
    Gynecol Oncol; 2004 Aug 01; 94(2):550-9. PubMed ID: 15297202
    [Abstract] [Full Text] [Related]

  • 11. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
    Huvila J, Talve L, Carpén O, Edqvist PH, Pontén F, Grénman S, Auranen A.
    Gynecol Oncol; 2013 Sep 01; 130(3):463-9. PubMed ID: 23777659
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Somatic molecular changes and histo-pathological features of colorectal cancer in Tunisia.
    Aissi S, Buisine MP, Zerimech F, Kourda N, Moussa A, Manai M, Porchet N.
    World J Gastroenterol; 2013 Aug 28; 19(32):5286-94. PubMed ID: 23983431
    [Abstract] [Full Text] [Related]

  • 14. Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma.
    Baldinu P, Cossu A, Manca A, Satta MP, Pisano M, Casula M, Dessole S, Pintus A, Tanda F, Palmieri G.
    Cancer; 2002 Jun 15; 94(12):3157-68. PubMed ID: 12115348
    [Abstract] [Full Text] [Related]

  • 15. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
    Peiró G, Peiró FM, Ortiz-Martínez F, Planelles M, Sánchez-Tejada L, Alenda C, Ceballos S, Sánchez-Payá J, Laforga JB.
    Hum Pathol; 2013 Feb 15; 44(2):218-25. PubMed ID: 22955108
    [Abstract] [Full Text] [Related]

  • 16. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
    Yang X, Dong Y, Zhang XM, Liang Y, Zhang Y, Meng YT, Wang Y, Wang W, Nong L, Li T, Liao QP.
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec 15; 40(12):799-804. PubMed ID: 22336203
    [Abstract] [Full Text] [Related]

  • 17. Cell cycle proteins predict recurrence in stage II and III colon cancer.
    Belt EJ, Brosens RP, Delis-van Diemen PM, Bril H, Tijssen M, van Essen DF, Heymans MW, Beliën JA, Stockmann HB, Meijer S, Meijer GA.
    Ann Surg Oncol; 2012 Jul 15; 19 Suppl 3():S682-92. PubMed ID: 22311118
    [Abstract] [Full Text] [Related]

  • 18. FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features.
    Byron SA, Gartside M, Powell MA, Wellens CL, Gao F, Mutch DG, Goodfellow PJ, Pollock PM.
    PLoS One; 2012 Jul 15; 7(2):e30801. PubMed ID: 22383975
    [Abstract] [Full Text] [Related]

  • 19. CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.
    Nakayama K, Rahman MT, Rahman M, Nakamura K, Ishikawa M, Katagiri H, Sato E, Ishibashi T, Iida K, Ishikawa N, Kyo S.
    Int J Oncol; 2016 Feb 15; 48(2):506-16. PubMed ID: 26647729
    [Abstract] [Full Text] [Related]

  • 20. The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms.
    Borie C, Colas C, Dartigues P, Lazure T, Rince P, Buhard O, Folliot P, Chalastanis A, Muleris M, Hamelin R, Mercier D, Oliveira C, Seruca R, Chadburn A, Leblond V, Barete S, Gaïdano G, Martin A, Gaulard P, Fléjou JF, Raphael M, Duval A.
    Int J Cancer; 2009 Nov 15; 125(10):2360-6. PubMed ID: 19551857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.